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Abstract
Background: Liver involvement, including elevated direct-reacting bilirubin levels, is common in patients with sickle
cell disease. Fifty to seventy percent of sickle cell patients have pigmented gallstones due to precipitation of
unconjugated bilirubin, and cholelithiasis or choledocholithiasis are common complications. The highest prevalence
of these complications occurs in patients with Gilbert’s syndrome because of the combined effect of increased
bilirubin production and reduced bilirubin-diphosphate-glucuronosyltransferase enzyme activity. Cholelithiasis is also
a common complication in patients with thalassemia. Endoscopic removal of choledochal stones does not always
resolve the clinical picture, as in cases of dysfunction of the Vater’s papilla, increased bile density due to persistently
impaired bile flow or distortion of the choledocus due to dilatation, or inflammation secondary to gallstone.
Case presentation: We report here a case of severe and persistent obstructive jaundice in a child affected with
thalassodrepanocytosis and Gilbert’s syndrome, previously, and unsuccessfully, treated with endoscopic removal of
choledochal stones. Deep and thorough biliary washing, and stenting with a new removable
polytetrafluoroethylene (PTFE)-covered flared-type stent led to complete resolution of the obstructive jaundice.
Conclusions: This report shows that an aggressive endoscopic approach in this select category of patients can
help resolve the severe complication of hemolytic anemia, thus avoiding surgery.
Background
Liver involvement is a common finding in patients with
sickle cell disease. Three principal clinical pictures have
been recognized: acute intrahepatic cholestasis, hepatic
crisis, and lithiasis [1-4]. Cholelithiasis and choledocho-
lithiasis are common complications in patients with
sickle cell disease or thalassemia. The highest prevalence
of these complications occurs in patients with Gilbert’s
syndrome. Endoscopic removal of choledochal stones
does not always resolve the clinical picture, as in cases
of dysfunction of the Vater’s papilla, increased bile
density due to persistently impaired bile flow or to dis-
tortion of the choledocus due to dilatation, or to inflam-
mation secondary to gallstones.
We report here a case of severe and persistent obstruc-
tive jaundice in a child affected with thalassodrepanocyto-
sis and Gilbert’s syndrome, previously and unsuccessfully
treated with endoscopic removal of choledochal stones.
Deep and thorough biliary washing, and stenting with a
new removable polytetrafluoroethylene (PTFE)-covered
stent led to complete resolution of the obstructive
jaundice.
Case Presentation
A 13-year-old boy, affected with thalassodrepanocytosis
(genotype S/b0) and Gilbert’s syndrome, presented with
cholestatic jaundice. He had no history of obstructive
jaundice, and had undergone prophylactic laparoscopic
cholecystectomy four years earlier. Liver chemistry tests
showed: total/direct reacting bilirubin 69/41 mg/dl, AST
150 U/L (normal: 5-40 U/L), ALT 100 U/L (normal: 10-65
U/L), alkaline phosphatase 165 U/L (normal: 40-134 U/L),
and gamma-GT 101 mg/l (normal: 5-85 U/L). A previous
ERCP showed choledochal dilation, with an angle in the
medium tract, and multiple small intraluminal filling
defects, attributable to gallstones. Despite sphincterotomy, * Correspondence: gcurcio@ismett.edu
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any medium, provided the original work is properly cited.gallstone removal and nose-biliary drainage placement, the
jaundice worsened and he was referred to our institute.
On admission, the patient was markedly jaundiced,
but asymptomatic. He had no history of alcohol intake,
viral infections or illicit drug use. His physical examina-
tion was remarkable for firm hepatomegaly, and scleral
and cutaneous jaundice.
A cholangiogram through the nose-biliary drainage
showed a dilated choledocus, with an angle in the med-
ium tract (Figure 1). Drainage was removed, and abun-
dant dense sludge was removed with a Fogarty balloon
catheter. Given the extreme density of the bile, the bili-
ary tree was thoroughly washed with a large amount of
sterile physiological solution (approximately 700 cc). In
order to achieve a better biliary flow, we decided to
place a biliary stent. Given the density of the bile, the
dilation and the angle of the choledocus, we decided to
place a self-expandable metal stent (SEMS), namely a
nitinol polytetrafluoroethylene (PTFE) full-covered
flared-type stent, 6 cm in length with 10 mm of dia-
meter, (Niti-S Biliary Covered Stent - Taewoong Medi-
cal Co., Korea), and not a plastic one. Compared to
plastic stents, metal stents offer the advantage of greater
diameter, thus avoiding the risk of migration and stent
occlusion, and the additional advantage of radial force,
which should correct the angle of the choledocus.
The stent was placed in the choledocus, across the
angle (Figure 2), draining a large amount of dense bile
(Figure 3). The procedure was uncomplicated.
Figure 1 Dilation of the common bile duct, with an angle in
the medial tract (arrow).
Figure 2 A PTFE-full covered self-expandable metallic stent is
placed in the common bile duct.
Figure 3 Metallic stent draining bile into the duodenum.
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was observed, and the patient was discharged home in
good general conditions, with laboratory tests showing
bilirubin tot/dir 9.29/0.37 mg/dl (0-1.5 mg/dL), AST/
ALT 82/68 U/L (normal: 5-40/65 U/L), alkaline phos-
phates 234 U/L (40-134 U/L), and gamma-GT 19 mg/l
(5-85 U/L).
The biliary stent was extracted 2 months later, and a
cholangiogram showed no filling defects, and resolution
of the biliary angle (Figure 4). The patient had no
further episodes of cholestatic jaundice during the one
year of follow-up. The indirect-reacting bilirubin level
remained high, fluctuating between 7 and 15 mg/dl,
with normal direct-reacting fraction, and no evidence of
biliary stone recurrence at ultrasonography.
Discussion
Liver involvement is a common finding in patients with
sickle cell disease. Three principal clinical pictures have
been recognized: acute intrahepatic cholestasis, hepatic
crisis and lithiasis [1-4]. Possible causes of acute intrahepa-
tic cholestasis and hepatic crisis are acute intrasinusoidal
sickling, with subsequent obstruction, and hepatic ische-
mia. Moreover, 50-70% of sickle cell patients have pigmen-
ted gallstones due to precipitation of unconjugated
bilirubin, and cholelithiasis or choledocholithiasis are
common complications [1,5,6]. The highest prevalence of
these complications occurs in patients with Gilbert’s syn-
drome because of the combined effect of increased biliru-
bin production and reduced bilirubin-diphosphate-
glucuronosyltransferase (UGT1-A1) enzyme activity [7,8].
Cholelithiasis is also a common complication in patients
with thalassemia. To avoid these clinical consequences,
elective cholecystectomy with appropriate preoperative
preparation is recommended for patients in whom
gallstones develop [9,10].
Cholelithiasis and choledocholithiasis can cause symp-
tomatic obstructive jaundice, with abdominal pain that
mimics painful vaso-occlusive events. A correct diagnosis
is critical, though challenging [11]. Endoscopic removal
of choledochal stones does not always resolve the clinical
picture, as in cases of dysfunction of the Vater’s papilla,
increased bile density due to persistently impaired bile
flow or to distortion of the choledocus due to dilatation,
or inflammation secondary to gallstones.
In this case, severe and persistent obstructive jaundice in
a child affected with thalassodrepanocytosis and Gilbert’s
syndrome was successfully resolved with deep and thor-
ough biliary washing, and stenting with a new removable
polytetrafluoroethylene (PTFE)-covered stent.
Conclusions
This report shows that obstructive jaundice in patients
with chronic biliary lithiasis can persist after gallstone
removal because of bile density and deformation of
chronically dilated choledocus.
An aggressive endoscopic approach, with thorough
biliary cleansing together with PTFE full-covered remo-
vable SEMS stenting in this select category of patients
can help resolve the severe complication of hemolytic
anemia, thus avoiding surgery.
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Figure 4 Cholangiography after stent removal, showing
resolutiom of biliary angle, no filling defects, and good biliary
drainage.
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